Free Trial

Commonwealth Equity Services LLC Invests $3.28 Million in Grail, Inc. (NASDAQ:GRAL)

Grail logo with Medical background
Remove Ads

Commonwealth Equity Services LLC purchased a new stake in shares of Grail, Inc. (NASDAQ:GRAL - Free Report) in the 4th quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor purchased 183,632 shares of the company's stock, valued at approximately $3,278,000. Commonwealth Equity Services LLC owned 0.55% of Grail as of its most recent SEC filing.

Other hedge funds and other institutional investors also recently made changes to their positions in the company. Douglas Lane & Associates LLC purchased a new stake in Grail during the fourth quarter valued at approximately $3,034,000. A. D. Beadell Investment Counsel Inc. bought a new stake in shares of Grail during the fourth quarter worth $430,000. FNY Investment Advisers LLC bought a new stake in Grail during the 4th quarter valued at $26,000. 180 Wealth Advisors LLC purchased a new stake in Grail during the fourth quarter worth $1,681,000. Finally, B & T Capital Management DBA Alpha Capital Management acquired a new stake in Grail in the fourth quarter valued at approximately $387,000.

Grail Stock Down 5.8 %

NASDAQ:GRAL traded down $1.65 during mid-day trading on Friday, hitting $26.93. The stock had a trading volume of 949,031 shares, compared to its average volume of 1,221,630. The stock has a 50-day simple moving average of $34.03 and a two-hundred day simple moving average of $22.41. Grail, Inc. has a twelve month low of $12.33 and a twelve month high of $63.99.

Grail (NASDAQ:GRAL - Get Free Report) last released its earnings results on Thursday, February 20th. The company reported ($1.86) earnings per share (EPS) for the quarter, topping the consensus estimate of ($4.41) by $2.55. The business had revenue of $38.25 million for the quarter, compared to analyst estimates of $35.33 million. As a group, equities research analysts predict that Grail, Inc. will post -15.15 earnings per share for the current fiscal year.

Remove Ads

Insider Buying and Selling

In related news, CFO Aaron Freidin sold 1,816 shares of the business's stock in a transaction dated Friday, March 7th. The shares were sold at an average price of $31.20, for a total transaction of $56,659.20. Following the completion of the sale, the chief financial officer now owns 335,170 shares of the company's stock, valued at $10,457,304. This represents a 0.54 % decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, President Joshua J. Ofman sold 2,109 shares of Grail stock in a transaction that occurred on Friday, March 7th. The shares were sold at an average price of $31.20, for a total value of $65,800.80. Following the sale, the president now directly owns 559,673 shares in the company, valued at approximately $17,461,797.60. This trade represents a 0.38 % decrease in their position. The disclosure for this sale can be found here. In the last quarter, insiders sold 11,550 shares of company stock valued at $360,436.

Wall Street Analyst Weigh In

Separately, Morgan Stanley raised their target price on shares of Grail from $16.00 to $20.00 and gave the stock an "equal weight" rating in a report on Tuesday, March 18th.

Read Our Latest Stock Analysis on Grail

Grail Company Profile

(Free Report)

GRAIL, Inc is a healthcare company. It engages in the development of a technology for early detection of cancer. The company was founded by Jeffrey T. Huber, William H. Rastetter, and Mostafa Ronaghi on September 11, 2015 and is headquartered in Menlo Park, CA.

See Also

Institutional Ownership by Quarter for Grail (NASDAQ:GRAL)

Should You Invest $1,000 in Grail Right Now?

Before you consider Grail, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Grail wasn't on the list.

While Grail currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

10 "Recession Proof" Stocks That Will Thrive in Any Market Cover

Which stocks are likely to thrive in today's challenging market? Enter your email address and we'll send you MarketBeat's list of ten stocks that will drive in any economic environment.

Get This Free Report
Like this article? Share it with a colleague.
Remove Ads

Featured Articles and Offers

Recent Videos

3 Bank Stocks Defying Market Turmoil—Cheap Options Trades!
Time to Buy SoFi? Fintech’s Next Big Move
3 Chip Stocks Primed for a Comeback—Have They Found the Bottom?

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines

Remove Ads